Array BioPharma Inc

Type: Company
Name: Array BioPharma Inc
Nationality: United States
Web Address: http://www.arraybiopharma.com/
First reported Jul 23 2014 - Updated 6 hours ago - 4 reports

Array BioPharma, Inc. (ARRY) Jumps: Stock Surges 10.7% Higher - Tale of the Tape

Array BioPharma, Inc. ( ARRY ) was a big mover last session, as the company saw its shares rise by nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend ... [Published Zacks.com - 6 hours ago]
First reported 21 hours ago - Updated 19 hours ago - 1 reports

Alexion Pharmaceuticals EPS Estimates More Optimistic Over Past Month

Leading up to Alexion Pharmaceuticals’  announcement of its second-quarter earnings on Thursday, July 24, 2014, analysts have become more bullish as expectations have improved over the past month from 97 cents per share to the current projection of earnings ... [Published Forbes.com - 21 hours ago]
First reported 21 hours ago - Updated 21 hours ago - 1 reports

Global concerns temper enthusiasm for earnings

The markets closed mixed with the Dow falling 26 points to 17,086 as concerns about global tensions tempered enthusiasm for corporate earnings. Nasdaq gained 17 points to 4,473.On the upsideSecond quarter earnings fell for Zix ( Nasdaq: ZIXI ) but the ... [Published Good Day Sacramento - 21 hours ago]
First reported 22 hours ago - Updated 22 hours ago - 1 reports

Mixed Session, Getting a Little Long in the Tooth

by Harry Boxer, www.TheTechTrader an AdviceTrade.com publication The stock market indices had a nice start to the session with a gap up. The indices then pulled back, and when support held they ran to the session highs about an hour into the session. ... [Published Individual.com - 22 hours ago]
First reported Jul 23 2014 - Updated Jul 23 2014 - 2 reports

Intuitive Surgical Rises On Upbeat Earnings; Xilinx Shares Slip

Midway through trading Wednesday, the Dow traded down 0.18 percent to 17,082.38 while the NASDAQ surged 0.41 percent to 4,474.24. The S&P also rose, gaining 0.19 percent to 1,987.23. Leading and Lagging Sectors In trading on Wednesday, healthcare shares ... [Published DailyMe.Com - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Why Oncotheryeon, Inc., OncoMed Pharmaceuticals, Inc., and Array BioPharma Inc. Stocks Jumped Today

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. So What: Neratinib's astronomical success in a phase 3 trial for increasing ... [Published Motley Fool - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 3 reports

WEDNESDAY'S ETF MOVERS : Xbi, soxx

In trading on Wednesday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 6.3% on the day. Components of that ETF showing particular strength include shares of Puma Biotechnology (PBYI), up about 291.1% and shares of Array Biopharma ... [Published 4 Traders - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 2 reports

Markets Mixed; PepsiCo Q2 Earnings Beat Street View

Following the market opening Wednesday, the Dow traded down 0.23 percent to 17,073.50 while the NASDAQ surged 0.22 percent to ...Related Stocks:Array Biopharma, Inc. BIOGEN IDEC Inc. Conmed Corp Intuitive Surgical Inc. JUNIPER NETWORKS, Inc. Knightsbridge ... [Published Minyanville - Jul 23 2014]
First reported Jul 22 2014 - Updated Jul 23 2014 - 1 reports

Interesting ARRY Put And Call Options For March 2015

Investors in Array BioPharma Inc. (ARRY) saw new options become available this week, for the March 2015 expiration.. ... [Published TVNewsCheck - Jul 22 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 1 reports

Executive Q&A: Nicholas Saccomano, CSO of Array BioPharma

In an interview with The Pharma Letter , Nicholas Saccomano, chief science officer of Array BioPharma (Nasdaq: ARRY), discusses its lead product filanesib, its partnerships with big pharma and why there are many more kinase targets to be discovered.Please ... [Published Pharma Letter - Jul 15 2014]
First reported Jul 03 2014 - Updated Jul 03 2014 - 1 reports

Study Updates, Market Activity, Preclinical Data, and Oral Presentations - Analyst Notes on Amicus, Conatus, Dicerna, Epizyme and Array

Today, released its analysts' notes regarding Amicus Therapeutics, Inc. (NASDAQ: FOLD), Conatus Pharmaceuticals Inc. (NASDAQ: CNAT), Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), Epizyme, Inc. (NASDAQ: EPZM) and Array BioPharma, Inc. (NASDAQ: ARRY). Private ... [Published Pettinga Financial Advisors - Jul 03 2014]
First reported May 28 2014 - Updated May 29 2014 - 2 reports

Array BioPharma, Biogen Idec enter drug discovery collaboration

US-based biopharmaceutical firm Array BioPharma has entered into collaboration agreement with Biogen Idec to discover and develop inhibitors targeting a new kinase for the treatment of autoimmune disorders. ... [Published PBR - News - May 29 2014]

Quotes

"We believe the company is experiencing good pipeline build and business activity from its user conference and the introduction of two new products" he writes...
...driver of lung cancer, and now here we are in May 2014 laying the groundwork for a clinical trial of drugs targeting this mutation," Doebele says. "Having seen this approach work well with other mutations in the past, the team is optimistic that this research could help control another important subset of lung cancers."
"I am honored to accept this role with the Arca Board of Directors," said Conway. "This is an exciting time for the organization with the GENETIC-AF trial under way. We believe there is an unmet medical need for new atrial fibrillation treatments. The GENETIC-AF trial, conducted with the collaboration of Medtronic, will hopefully provide important new data for the atrial fibrillation community."
...Christian Hutter noted the company is delighted to add this leading biopharmaceutical company to its growing base of life sciences customers. "We look forward to helping Array BioPharma meet its strategic goals through this implementation" Hutter added. Junction Solutions supports the production and distribution of pharmaceutical products from planning to execution...

More Content

All (63) | News (31) | Reports (0) | Blogs (25) | Audio/Video (0) | Fact Sheets (0) | Press Releases (7)
sort by: Date | Relevance
Array BioPharma, Inc. (ARRY) Jumps: Stock Surge... [Published Zacks.com - 6 hours ago]
Array BioPharma, Inc. (ARRY) Jumps: Stock Surge... [Published Nasdaq - 6 hours ago]
Array BioPharma, Inc. (ARRY) Jumps: Stock Surge... [Published Yahoo! Finance - 8 hours ago]
Alexion Pharmaceuticals EPS Estimates More Opti... [Published Forbes.com - 21 hours ago]
Global concerns temper enthusiasm for earnings [Published Good Day Sacramento - 21 hours ago]
Mixed Session, Getting a Little Long in the Tooth [Published Individual.com - 22 hours ago]
Intuitive Surgical Rises On Upbeat Earnings; Xi... [Published DailyMe.Com - Jul 23 2014]
Intuitive Surgical Rises On Upbeat Earnings; Xi... [Published Minyanville - Jul 23 2014]
Why Oncotheryeon, Inc., OncoMed Pharmaceuticals... [Published Motley Fool - Jul 23 2014]
WEDNESDAY'S ETF MOVERS : Xbi, soxx [Published 4 Traders - Jul 23 2014]
Wednesday's ETF Movers: XBI, SOXX [Published Forbes.com - Jul 23 2014]
Wednesday's ETF Movers: XBI, SOXX [Published Atlanta Journal And Constitution - Jul 23 2014]
BUZZ-U.S. Stocks on the Move-Apple, Microsoft, ... [Published London South East - Jul 23 2014]
Markets Mixed; PepsiCo Q2 Earnings Beat Street ... [Published Minyanville - Jul 23 2014]
Markets Mixed; PepsiCo Q2 Earnings Beat Street ... [Published Benzinga.com - Jul 23 2014]
Array Biopharma Up 14.9%, Shares Break Through ... [Published Individual.com - Jul 23 2014]
Interesting ARRY Put And Call Options For March... [Published TVNewsCheck - Jul 22 2014]
Wall Street Sees Massive Upside In These 3 Litt... [Published StreetAuthority - Jul 17 2014]
Executive Q&A: Nicholas Saccomano, CSO of Array... [Published Pharma Letter - Jul 15 2014]
Biotech Stocks Highlight -- Research on Celgene... [Published Financial Services - Jul 09 2014]
Study Updates, Market Activity, Preclinical Dat... [Published Pettinga Financial Advisors - Jul 03 2014]
Study Updates, Market Activity, Preclinical Dat... [Published Financial Services - Jul 03 2014]
ALK, ROS1 and now NTRK1: Study shows prevalence... [Published Pharmacy Choice - Jun 17 2014]
Arca biopharma Appoints Robert Conway as Chairm... [Published Pharmacy Choice - Jun 17 2014]
Cramer's Lightning Round - Panera Bread Won't R... [Published Seeking Alpha - Jun 15 2014]
Array BioPharma To Present At The Wells Fargo S... [Published PR Newswire: General Business - Jun 11 2014]
Health Care Sector Equities Coverage -- Researc... [Published Financial Services - Jun 06 2014]
The Zacks Analyst Blog Highlights: Facebook, AT... [Published PR Newswire - May 30 2014]
Frontrunning: May 30 [Published Zero Hedge - May 30 2014]
Array BioPharma, Biogen Idec enter drug discove... [Published PBR - News - May 29 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Array BioPharma To Present At The Wells Fargo S... [Published PR Newswire: General Business - Jun 11 2014]
BOULDER, Colo., June 11, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities 2014 Healthcare Conference in Boston.  The public is welcome ...
Frontrunning: May 30 [Published Zero Hedge - May 30 2014]
Ukraine Rebels Outfox Army to Dent Poroshenko Troop Goal ( BBG ) Russia Withdraws Most of Forces From Ukraine Border: U.S. ( BBG ) Super-Size Me! China’s ’Mini’ Stimulus Starts Expanding ( BBG ) Option B: The blueprint for Thailand's coup ( Reuters ) ...
Array BioPharma, Biogen Idec enter drug discove... [Published PBR - News - May 29 2014]
US-based biopharmaceutical firm Array BioPharma has entered into collaboration agreement with Biogen Idec to discover and develop inhibitors targeting a new kinase for the treatment of autoimmune disorders. ...
Array BioPharma Announces Drug Discovery Collab... [Published PR Newswire: Health - May 28 2014]
BOULDER, Colo., May 28, 2014 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) announced today a collaboration agreement with Biogen Idec (NASDAQ: BIIB) for the discovery and development of inhibitors targeting a novel kinase for the treatment of autoimmune ...
Array BioPharma To Present At The Jefferies 201... [Published PR Newswire: General Business - May 27 2014]
BOULDER, Colo., May 27, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Jefferies 2014 Global Healthcare Conference in New York City.  The public is welcome ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
Biotech Stocks Highlight -- Research on Celgene... [Published Financial Services - Jul 09 2014]
Study Updates, Market Activity, Preclinical Dat... [Published Financial Services - Jul 03 2014]
Health Care Sector Equities Coverage -- Researc... [Published Financial Services - Jun 06 2014]
Top Gainers Technical Data -- Research on BioSc... [Published Financial Services - May 12 2014]
Biotech Stocks Analysis -- Research on Array Bi... [Published Financial Services - Mar 28 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.